Invention Grant
- Patent Title: Compounds-801
- Patent Title (中): 化合物-801
-
Application No.: US13617978Application Date: 2012-09-14
-
Publication No.: US08476265B2Publication Date: 2013-07-02
- Inventor: Lilian Alcaraz , Andrew Bailey , Nicholas Kindon
- Applicant: Lilian Alcaraz , Andrew Bailey , Nicholas Kindon
- Applicant Address: SE Sodertalje GB Essex
- Assignee: AstraZeneca AB,Pulmagen Therapeutics (Synergy) Limited
- Current Assignee: AstraZeneca AB,Pulmagen Therapeutics (Synergy) Limited
- Current Assignee Address: SE Sodertalje GB Essex
- Agency: Fish & Richardson P.C.
- Priority: GB09113342.2 20100730
- Main IPC: C07D498/10
- IPC: C07D498/10 ; A61K31/5386
Abstract:
Spirocyclic amide derivatives of formula I wherein ArCH2CH2NH— represents a β-adrenoceptor binding group, processes for their preparation, pharmaceutical compositions containing them, a process for preparing such pharmaceutical compositions, their use in therapy, and intermediates for use in their preparation.
Public/Granted literature
- US20130018037A1 Compounds - 801 Public/Granted day:2013-01-17
Information query
